Literature DB >> 30421627

Metformin can inhibit Helicobacter pylori growth.

Sarah Courtois1, Lucie Bénéjat1,2, Julien Izotte3, Francis Mégraud1,2, Christine Varon1, Philippe Lehours1,2, Emilie Bessède1,2.   

Abstract

AIM: Helicobacter pylori infection is a worldwide infection, its eradication rates with conventional therapies have fallen to unacceptable levels. In this context we were interested in metformin, to determine its effect on H. pylori growth. MATERIALS &
METHODS: Antimicrobial susceptibility tests and survival curves were performed in vitro and a H. pylori-infected mice model was used to determine metformin effect in vivo.
RESULTS: Helicobacter pylori survival and growth were decreased in presence of metformin. Furthermore, metformin-treated mice had significantly less bacteria in their stomach than the untreated mice.
CONCLUSION: Our work is the first to demonstrate a direct antimicrobial effect of metformin on H. pylori, indicating that this molecule has not yet revealed its full potential.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30421627     DOI: 10.2217/fmb-2018-0184

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  8 in total

1.  Autophagy induced by Helicobacter pylori infection is necessary for gastric cancer stem cell emergence.

Authors:  Sarah Courtois; Maria Haykal; Clément Bodineau; Elodie Sifré; Lamia Azzi-Martin; Armelle Ménard; Francis Mégraud; Philippe Lehours; Raúl V Durán; Christine Varon; Emilie Bessède
Journal:  Gastric Cancer       Date:  2020-09-17       Impact factor: 7.370

Review 2.  The therapeutic potential of metformin in gastric cancer.

Authors:  Sarah Courtois; Philippe Lehours; Emilie Bessède
Journal:  Gastric Cancer       Date:  2019-03-21       Impact factor: 7.370

3.  Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies.

Authors:  Huoyan Liang; Xianfei Ding; Lifeng Li; Tian Wang; Quancheng Kan; Lexin Wang; Tongwen Sun
Journal:  Crit Care       Date:  2019-02-18       Impact factor: 9.097

Review 4.  Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?

Authors:  Axel Dalhoff
Journal:  Infection       Date:  2020-12-15       Impact factor: 3.553

5.  Outcomes after surgery in patients with diabetes who used metformin: a retrospective cohort study based on a real-world database.

Authors:  Ta-Liang Chen; Chien-Chang Liao; Chao-Shun Lin; Chuen-Chau Chang; Chun-Chieh Yeh; Yi-Cheng Chang
Journal:  BMJ Open Diabetes Res Care       Date:  2020-11

6.  Metformin Alters the Chemotaxis and Flagellar Motility of Escherichia coli.

Authors:  Yingxiang Ye; Panmei Jiang; Chengyun Huang; Jingyun Li; Juan Chen; Lu Wang; Yan Lin; Fangbin Wang; Jian Liu
Journal:  Front Microbiol       Date:  2022-01-11       Impact factor: 5.640

7.  Effect of metformin on the eradication of H.Pylori infection in 25 -75 years old patients referring Loghman Hakim Hospital.

Authors:  Shahriar Nikpour; Mohammad Salehi; Sina Homaee; Farnaz Saberian; Saeid Kalbasi
Journal:  Caspian J Intern Med       Date:  2022

Review 8.  Chemopreventive Effect of Metformin on Gastric Cancer Development.

Authors:  Ka Shing Cheung; Kit Lam Chung; Wai K Leung
Journal:  Gut Liver       Date:  2022-03-15       Impact factor: 4.519

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.